CoChat

Diabetes Is Reversed in a Murine Model by Marginal Mass Syngeneic Islet Transplantation Using a Subcutaneous Cell Pouch Device

Open access
Pepper, Andrew R., Pawlick, Rena, Gala-Lopez, Boris, MacGillivary, Amanda, Mazzuca, Delfina M., White, David J. G., Toleikis, Philip M., Shapiro, A. M. James · 2015 · Transplantation
Cited by 116

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Islet transplantation is a successful β-cell replacement therapy for selected patients with type 1 diabetes mellitus. Although high rates of early insulin independence are achieved routinely, long-term function wanes over time. Intraportal transplantation is associated with procedural risks, requires multiple donors, and does not afford routine biopsy. Stem cell technologies may require potential for retrievability, and graft removal by hepatectomy is impractical. There is a clear clinical need for an alternative, optimized transplantation site. The subcutaneous space is a potential substitute, but transplantation of islets into this site has routinely failed to reverse diabetes. However, an implanted device, which becomes prevascularized before transplantation, may alter this equation. METHODS: Syngeneic mouse islets were transplanted subcutaneously within Sernova Corp's Cell Pouch (CP). All recipients were preimplanted with CPs 4 weeks before diabetes induction and transplantation. After transplantation, recipients were monitored for glycemic control and glucose tolerance. RESULTS: Mouse islets transplanted into the CP routinely restored glycemic control with modest delay and responded well to glucose challenge, comparable to renal subcapsular islet grafts, despite a marginal islet dose, and normoglycemia was maintained until graft explantation. In contrast, islets transplanted subcutaneously alone failed to engraft. Islets within CPs stained positively for insulin, glucagon, and microvessels. CONCLUSIONS: The CP is biocompatible, forms an environment suitable for islet engraftment, and offers a potential alternative to the intraportal site for islet and future stem cell therapies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/tp.0000000000000864

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 32

  1. Harlan, 2009, Current advances and travails in islet transplantation., Diabetes, 58, 2175, 10.2337/db09-0476 · DOI · Paper page
  2. Pepper, 2013, Revascularization of transplanted pancreatic islets and role of the transplantation site., Clin Dev Immunol, 2013, 352315, 10.1155/2013/352315 · DOI · Paper page
  3. Plesner, 2011, Advances and challenges in islet transplantation: islet procurement rates and lessons learned from suboptimal islet transplantation., J Transplant, 2011, 979527, 10.1155/2011/979527 · DOI · Paper page
  4. Cheng, 2005, Islet transplantation for diabetic rats through the spleen., Hepatobiliary Pancreat Dis Int, 4, 203
  5. White, 2000, The risks of total pancreatectomy and splenic islet autotransplantation., Cell Transplant, 9, 19, 10.1177/096368970000900103 · DOI
  6. Rajab, 2008, Comparison of the portal vein and kidney subcapsule as sites for primate islet autotransplantation., Cell Transplant, 17, 1015, 10.3727/096368908786991533 · DOI
  7. Pattou, 2010, GLP-1-receptor scanning for imaging of human beta cells transplanted in muscle., N Engl J Med, 363, 1289, 10.1056/NEJMc1004547 · DOI · Paper page
  8. Echeverri, 2009, Endoscopic gastric submucosal transplantation of islets (ENDO-STI): technique and initial results in diabetic pigs., Am J Transplant, 9, 2485, 10.1111/j.1600-6143.2009.02815.x · DOI
  9. Kakabadze, 2011, Long-term engraftment and function of transplanted pancreatic islets in vascularized segments of small intestine., Transpl Int, 24, 175, 10.1111/j.1432-2277.2010.01160.x · DOI
  10. Kakabadze, 2013, Correction of diabetes mellitus by transplanting minimal mass of syngeneic islets into vascularized small intestinal segment., Am J Transplant, 13, 2550, 10.1111/ajt.12412 · DOI
  11. Kakabadze, 2012, An isolated venous sac as a novel site for cell therapy in diabetes mellitus., Transplantation, 94, 319, 10.1097/TP.0b013e31825e4a83 · DOI
  12. Berman, 2009, Long-term survival of nonhuman primate islets implanted in an omental pouch on a biodegradable scaffold., Am J Transplant, 9, 91, 10.1111/j.1600-6143.2008.02489.x · DOI · Paper page
  13. Maffi, 2013, Autologous pancreatic islet transplantation in human bone marrow., Diabetes, 62, 3523, 10.2337/db13-0465 · DOI · Paper page
  14. Tuch, 2009, Safety and viability of microencapsulated human islets transplanted into diabetic humans., Diabetes Care, 32, 1887, 10.2337/dc09-0744 · DOI · Paper page
  15. Sakata, 2014, Strategy for clinical setting in intramuscular and subcutaneous islet transplantation., Diabetes Metab Res Rev, 30, 1, 10.1002/dmrr.2463 · DOI · Paper page
  16. Pileggi, 2006, Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device., Transplantation, 81, 1318, 10.1097/01.tp.0000203858.41105.88 · DOI · Paper page
  17. Toso, 2010, Liraglutide, a long-acting human glucagon-like peptide 1 analogue, improves human islet survival in culture., Transpl Int, 23, 259, 10.1111/j.1432-2277.2009.00984.x · DOI · Paper page
  18. Kemp, 1973, Effect of transplantation site on the results of pancreatic islet isografts in diabetic rats., Diabetologia, 9, 486, 10.1007/BF00461694 · DOI · Paper page
  19. Lacy, 1991, Maintenance of normoglycemia in diabetic mice by subcutaneous xenografts of encapsulated islets., Science, 254, 1782, 10.1126/science.1763328 · DOI · Paper page
  20. Juang, 1996, Outcome of subcutaneous islet transplantation improved by polymer device., Transplantation, 61, 1557, 10.1097/00007890-199606150-00001 · DOI · Paper page
  21. Ludwig, 2012, Improvement of islet function in a bioartificial pancreas by enhanced oxygen supply and growth hormone releasing hormone agonist., Proc Natl Acad Sci U S A, 109, 5022, 10.1073/pnas.1201868109 · DOI · Paper page
  22. Kim, 2012, In situ application of hydrogel-type fibrin-islet composite optimized for rapid glycemic control by subcutaneous xenogeneic porcine islet transplantation., J Control Release, 162, 382, 10.1016/j.jconrel.2012.07.018 · DOI
  23. Perez-Basterrechea, 2009, Plasma-fibroblast gel as scaffold for islet transplantation., Tissue Eng Part A, 15, 569, 10.1089/ten.tea.2008.0088 · DOI
  24. Dufrane, 2010, Alginate macroencapsulation of pig islets allows correction of streptozotocin-induced diabetes in primates up to 6 months without immunosuppression., Transplantation, 90, 1054, 10.1097/TP.0b013e3181f6e267 · DOI · Paper page
  25. Ludwig, 2013, Transplantation of human islets without immunosuppression., Proc Natl Acad Sci U S A, 110, 19054, 10.1073/pnas.1317561110 · DOI · Paper page
  26. Sorenby, 2008, Preimplantation of an immunoprotective device can lower the curative dose of islets to that of free islet transplantation: studies in a rodent model., Transplantation, 86, 364, 10.1097/TP.0b013e31817efc78 · DOI · Paper page
  27. Wilson, 2008, Challenges and emerging technologies in the immunoisolation of cells and tissues., Adv Drug Deliv Rev, 60, 124, 10.1016/j.addr.2007.08.034 · DOI · Paper page
  28. Sterkers, 2013, Islet survival and function following intramuscular autotransplantation in the minipig., Am J Transplant, 13, 891, 10.1111/ajt.12136 · DOI
  29. Pileggi, 2001, Factors influencing Islet of Langerhans graft function and monitoring., Clin Chim Acta, 310, 3, 10.1016/S0009-8981(01)00503-4 · DOI
  30. Bennet, 2000, Isolated human islets trigger an instant blood mediated inflammatory reaction: implications for intraportal islet transplantation as a treatment for patients with type 1 diabetes., Ups J Med Sci, 105, 125, 10.1517/03009734000000059 · DOI · Paper page
  31. Roep, 1999, Auto- and alloimmune reactivity to human islet allografts transplanted into type 1 diabetic patients., Diabetes, 48, 484, 10.2337/diabetes.48.3.484 · DOI · Paper page
  32. Jones, 2007, Time course and quantification of pancreatic islet revascularization following intraportal transplantation., Cell Transplant, 16, 505, 10.3727/000000007783464993 · DOI

Cited by

See all 116

Metadata

Authors
Pepper, A. R., Pawlick, R., Gala-Lopez, B., MacGillivary, A., Mazzuca, D. M., White, D. J. G., Toleikis, P. M., & Shapiro, A. M. J.
Venue
Transplantation
Published
2015-11
Volume
99
Issue
11
Pages
2294-2300
ISSN
0041-1337 (ISSN-L)
OpenAlex
W2260094956
Cited by
116
References
5
FWCI
12.73
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Diabetes Is Reversed in a Murine Model by Marginal Mass Syngeneic Islet Transplantation Using a Subcutaneous Cell Pouch Device. https://app.cochat.ai/papers/10.1097/tp.0000000000000864
The paper
Pepper, A. R., Pawlick, R., Gala-Lopez, B., MacGillivary, A., Mazzuca, D. M., White, D. J. G., Toleikis, P. M., & Shapiro, A. M. J. (2015). Diabetes Is Reversed in a Murine Model by Marginal Mass Syngeneic Islet Transplantation Using a Subcutaneous Cell Pouch Device. Transplantation. https://doi.org/10.1097/tp.0000000000000864

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.